Carregant...
Gastrointestinal adverse events associated with immune checkpoint inhibitor therapy
Immunotherapy with checkpoint inhibitors has revolutionized cancer therapy and is now the standard treatment for several different types of cancer, supported by favorable outcomes and good tolerance. However, it is linked to multiple immune manifestations, referred to as immune-related adverse event...
Guardat en:
| Publicat a: | Gastroenterol Rep (Oxf) |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7034236/ https://ncbi.nlm.nih.gov/pubmed/32104583 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/gastro/goz065 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|